Drug Shortage Report for VINORELBINE INJECTION
Report ID | 103730 |
Drug Identification Number | 02265990 |
Brand name | VINORELBINE INJECTION |
Common or Proper name | Vinorelbine Injetion |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VINORELBINE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 ml |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-12-14 |
Estimated end date | 2021-11-29 |
Actual end date | 2021-06-01 |
Shortage status | Resolved |
Updated date | 2022-03-03 |
Company comments | Old DIN has been moved to Dormant- New DIN (02511347) to be made available November 29, 2021 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-03-03 | French | Compare |
v10 | 2022-03-03 | English | Compare |
v9 | 2021-08-12 | French | Compare |
v8 | 2021-08-12 | English | Compare |
v7 | 2020-01-22 | French | Compare |
v6 | 2020-01-22 | English | Compare |
v5 | 2020-01-22 | French | Compare |
v4 | 2020-01-22 | English | Compare |
v3 | 2020-01-21 | English | Compare |
v2 | 2020-01-20 | French | Compare |
v1 | 2020-01-20 | English | Compare |
Showing 1 to 11 of 11